Briacell Therapeutics Corp (BCTX)
US$ 4.040.75%
Price Chart
Key Statistics
Market Cap
$ 18.48M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
36.55K
52W High
$ 36.60
52W Low
$ 3.00
Dividend Yield
0.00%
Beta
1.71
Technicals
50-Day MA
4.1554
200-Day MA
1.8148
52 Week High
36.6
52 Week Low
3
About BCTX
BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care.
Employees
N/A
Headquarters
West Vancouver, BC
CEO
Dr. William V. Williams FCPA, M.D.
Latest News
BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering - GlobeNewswire
5 days ago • Google News
BriaCell (BCTX) Reveals Promising Phase 2 and Preclinical Data a - GuruFocus
Yesterday • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg